Maria V Lopez-Bresnahan

Maria V Lopez-Bresnahan, MD, MBA, FAAN is VP, Clinical Development, Neurology & Addiction, Alkermes, Inc.

Dr. Maria Lopez-Bresnahan is a biopharmaceutical executive, currently VP of Clinical Research, Neuroscience at Alkermes, Inc.  She served previously at Vertex Pharmaceuticals as VP of Neurology Clinical Development and at Pfizer Inc. as Head of Neuromuscular Clinical Research in the Rare Disease Research Unit and as Therapeutic Area Head for Neuroscience in the Medicines Development Group leading drug development strategy and planning for neurology and psychiatry.

Dr. Lopez-Bresnahan held leadership positions at Merck Serono responsible for global development of CNS drugs.  She served as SVP and Global Head for Medical and Scientific Affairs at inVentiv Health, leading subspecialty medical teams executing development programs for pharmaceutical clients.

Dr. Lopez-Bresnahan received a BA from Yale University, MS from Georgetown University, MBA from Northeastern University, and an MD from New York University School of Medicine. A Fellow of the American Academy of Neurology, she completed her neurology training at the Massachusetts General Hospital and the Harvard Medical School, where she served as Assistant Clinical Professor of Neurology.